, /PRNewswire/ -- The global proteomics market size is estimated to grow by .99 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 16.
83% during the forecast period. Increasing advances in proteomics research is driving market growth, with a trend towards growing focus on monitoring PTMS. However, shortage of trained laboratory professionals poses a challenge.
Key market players include Agilent Technologies Inc., Applied Biomics Inc., Bio Rad Laboratories Inc.
, Biognosys AG, Bruker Corp., Cell Signaling Technology Inc., CellCarta Biosciences Inc.
, Creative Proteomics, DiaSorin Spa, F. Hoffmann La Roche Ltd., Geno Technology Inc.
, HORIBA Ltd., Illumina Inc., Merck KGaA, Olink Holding AB, Perkin Elmer Inc.
, Promega Corp., QIAGEN NV, Thermo Fisher Scientific Inc., and Waters Corp.
. Get a detailed analysis on regions, market segments, customer landscape, and companies- The proteomics market has witnessed notable expansion in recent years due to the escalating demand for sophisticated diagnostic tools and personalized medicine. A prominent trend in this sector is the heightened attention towards monitoring post-translational modifications (PTMs) of proteins.
PTMs are modifications that take place after a protein is translated from its genetic code. These alterations can influence a protein's function, activity, and localization, significantly impacting biological processes. The identification and quantification of PTMs offer essenti.
